William Enright
Chief Executive Officer at BARINTHUS BIOTHERAPEUTICS PLC
Net worth: 3 M $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gemma Brown | M | 34 | 3 years | |
| Karen Dawes | F | 72 |
Vaccitech (UK) Ltd.
 Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom. | 3 years |
| Joseph Scheeren | M | 68 |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom. | 3 years |
| Anne Phillips | M | 70 |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom. | 3 years |
| Thomas Evans | M | 69 |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom. | 5 years |
| Adrian Hill | M | - |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom. | 8 years |
| Mitchel Sayare | M | 76 | 14 years | |
| Vipin K. Garg | M | 67 | 6 years | |
| David Drutz | M | 86 | 14 years | |
| Vininder Singh | M | 55 | 7 years | |
| Sarah Gilbert | F | - |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom. | 8 years |
| Robin Wright | M | 59 |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom. | 6 years |
| Pierre Armand Morgon | M | 61 |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom. | 7 years |
| Jonothan Blackbourn | M | - | 2 years | |
| Alex Hammacher | M | 43 |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom. | 5 years |
| Chris Ellis | M | 64 |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom. | 8 years |
| M. Roberts | M | 65 |
Wellstat Biologics Corp.
 Wellstat Biologics Corp. Pharmaceuticals: MajorHealth Technology Wellstat Biologics Corp. is a private company that focuses on the development and commercialization of biological agents. The company is based in Gaithersburg, MD. | 27 years |
| Jason Hanson | M | 55 | 1 years | |
| Klaus Schafer | M | 74 | 12 years | |
| Wayne Pisano | M | 69 | 6 years | |
| R. Elsey | M | 71 | 1 years | |
| Kristin Bigos | M | - | - | |
| David Recker | M | 66 | - | |
| Andrew James McLean | M | 39 |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom. | - |
| Adam Stoten | M | - |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom. | - |
| Bertrand Georges | M | - | 9 years | |
| Billl Hirschman | M | - | - | |
| Graham Griffiths | M | 45 | 7 years | |
| Steven N. Chatfield | M | 67 |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom. | - |
| JT Koffenberger | M | - | - | |
| Nadège Pelletier | M | 46 | 1 years | |
| Dane Saglio | M | 66 | 3 years | |
| Toby Sayre | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas Smart | M | - |
Gravitas Therapeutics, Inc.
 Gravitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Gravitas Therapeutics, Inc. is an American clinical-stage company that provides antifungal treatment for aspergillus mold infections. The CEO of the private company is Thomas E. Smart. | - |
| William Brown | M | 42 | 3 years | |
| Philip MacNeill | M | 70 | 2 years | |
| Elizabeth Czerepak | F | 58 | 3 years | |
| Georgy Egorov | M | 48 | - | |
| Kent Tapper | M | 63 | 8 years | |
| Jose Ochoa | M | - | 5 years | |
| Carl David Vine | M | 49 | - | |
| Sybil Tasker | M | - | 2 years | |
| Andrew James Mclean | M | 39 | 3 years | |
| Margaret Marshall | M | 67 | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 23 | 52.27% |
| United Kingdom | 21 | 47.73% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- William Enright
- Personal Network
